To complement the RNA-seq and qRT-PCR data derived from our isogenic SF3B1 cell model, similar analyses were conducted on CD34+-enriched bone marrow samples taken from MDS patients [21] (Fig. S7C) and matched lung mesothelioma cell lines (Fig. S7D), with and without the SF3B1K700E mutation. This evidence concerns the gene CD34 and myelodysplastic syndrome.